Web Results

Vasoactivity - Wikipedia

en.wikipedia.org/wiki/Vasoactivity

A vasoactive substance is an endogenous agent or pharmaceutical drug that has the effect of ... Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization...

VASO ACTIVE PHARMACEUTICALS INC (VAPH) IPO - NASDAQ.com

www.nasdaq.com/markets/ipos/company/vaso-active-pharmaceuticals-inc-406348-34430

Company Name, VASO ACTIVE PHARMACEUTICALS INC. Company Address, 99 ROSEWOOD DRIVE, #260. DANVERS, MA 01923. Company Phone ...

Vaso Active Pharmaceuticals, Inc. : Lit. Rel. No. 18834 / August 17 ...

www.sec.gov/litigation/litreleases/lr18834.htm

Aug 17, 2004 ... Litigation Release No. 18834 / August 17, 2004. SEC Files Settled Action Charging Vaso Active Pharmaceuticals, Inc. and its President and ...

Matthew Carter | LinkedIn

www.linkedin.com/in/matthew-carter-3014a423

Willow Laboratories,; Vaso Active Pharmaceuticals,; Aquamer ... The company provides diagnostic drug testing services with a focus on substance abuse ...

NuGen Mobility Inc.: BIOS

www.ngmcorp.com/Bios.htm

From September 2004 until August 2005, Mr. Toh served as a director of Vaso Active Pharmaceuticals Inc. Since 1992, Mr. Toh has served as an officer and ...

PhaseBio Receives FDA Orphan Drug Designation for Vasomera ...

www.phasebio.com/pages/news/releases/PhaseBioReceivesFDAOrphanDrugDesignationforVasomeraPB1046fortheTreatmentofCardiomyopath..php

Malvern, PA, December 1, 2015 — PhaseBio Pharmaceuticals, Inc., ... PB1046 is based on Vasoactive Intestinal Peptide (VIP), a naturally occurring ...

Executive Management - Acadia Healthcare

www.acadiahealthcare.com/investors/executive-management

Prior to joining the Company in 2011, he co-founded Psychiatric Solutions, Inc. ... of Directors of Vaso Active Pharmaceuticals, Inc., a company marketing and ...

Cases | A.B. Data Class Action Administration

www.abdataclassaction.com/cases/

Aventis Pharmaceuticals, Inc., Ferring B.V., and Ferring Pharmaceuticals, Inc. In re: DDAVP ...... In re Vaso Active Pharmaceuticals, Inc. Derivative Litigation.

Chronic treatment with PB1046, a stable and long-acting vasoactive ...

www.phasebio.com/pdf/Roof SR et al 2015 Chronic treatment with PB1046, a stable and long-acting VIP receptor agonist, improves cardiac and skeletal muscle function in mouse models of DMD.pdf

VPAC2 receptor agonist comprising vasoactive intestinal .... L Georgopoulos, S Arnold and CL del Rio have stock options in PhaseBio Pharmaceuticals, Inc.

Newsroom - PhaseBio

www.phasebio.com/pages/news/releases/031215.php

Malvern, PA, March 12, 2015 — PhaseBio Pharmaceuticals, Inc., a leading ... once-weekly Vasoactive Intestinal Peptide (PB1046) into separate Phase 2a trials ...

More Info

Vaso Active Pharmaceuticals, Inc.: OTCMKTS:VAPHQ quotes ...

www.google.com

Vaso Active Pharmaceuticals, Inc. is a company focused on commercializing, marketing and selling over-the-counter (OTC) pharmaceutical products. Vaso ...

vasoactive.us - Registered at Namecheap.com

www.vasoactive.us

vasoactive.us. 2016 Copyright. All Rights Reserved. The Sponsored Listings displayed above are served automatically by a third party. Neither Parkingcrew nor ...

In re Vaso Active Pharmaceuticals: A Study in ... - Eckert Seamans

www.eckertseamans.com

In re Vaso Active Pharmaceuticals: A Study in Fraudulent Transfers to ... BioChemics Inc. BioChemics was also founded and controlled by Masiz, its majority.